Recover password

Seattle biotech acquires ABQ’s Alpine Biosciences in $27 million deal


Sandia Labs researcher Carlee Ashley introduces a buffer into a protocell solution as Sandia researcher and UNM professor Jeff Brinker watches in this file photo. Alpine Biosciences, which spun out the protocell tech into a new company, has been acquired by Oncothyreon Inc. out of Seattle in a deal valued at $27 million.